Apollon Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Apollon Wealth Management's ABBV Position: Q3 2026 in Review
Apollon Wealth Management increased its AbbVie (ABBV) stake by 19% in Q3 2026, buying an estimated $5.83M and bringing the position to 145,103 shares worth $38M. The position accounts for 0.44% of the portfolio, ranked #45.
Apollon Wealth Management first reported a position in ABBV in Q2 2020 and has held it in 26 quarters since. 4,279 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Apollon Wealth Management held 145,103 shares of AbbVie worth $38M as of Q3 2026.
- Apollon Wealth Management bought 22,722 AbbVie shares in Q3 2026, an estimated $5.83M.
- AbbVie made up 0.44% of Apollon Wealth Management's portfolio in Q3 2026, its #45 holding.
- Apollon Wealth Management first reported a position in AbbVie in Q2 2020 and has held it in 26 quarters since.
- 4,279 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Apollon Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.